Clinical trial · Observational
LCCC1931:Post-treatment Intervention in Women With Breast Cancer (70y/o+)
LCCC1931: Interventions to Address Symptoms and Deficits in Women Age 70 Plus During the First Year Post Primary Treatment for Early Breast Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study recruits woman over the age of 70 who have completed primary treatment for early breast cancer in the last 2 months. A survey called the geriatric assessment will be used to identify symptoms and issues participants experience.This information will be given to the patient's medical oncology team, and used to make referrals to specialists. This study is designed to determine if these assessments and timely interventions can be completed during clinic visits, and determine if these participants comply with recommendations.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Referrals Recommendations | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Geriatric Assessment
- description
- Participants fill out the geriatric assessment during a clinic visit and receive recommendations based on results
- interventionNames
- Other: Referrals Recommendations
Primary outcomes (1)
- measure
- Percentage of Participants who agree to referral
- timeFrame
- 3 years
- description
- Number of participants who agree to suggested referral within 1-2 weeks of consent
Secondary outcomes (6)
- measure
- Percentage of referral acceptance among participants with function deficits, as identified by the geriatric assessment
- timeFrame
- 3 years
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Women aged 70 or older * within 6 months of complete primary treatment (surgery, chemotherapy, targeted therapy, or radiation) for breast cancer (Stage I-III) * Able to read English * Willing and capable of providing informed consent Exclusion Criteria: -Has dementia, altered mental status, or any psychiatric or co-morbid condition prohibiting the understanding or rendering of informed consent.
References
Publications (0)
Data not yet available